| D |
2026-05-21 16:04 |
2026-05-20 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
M - OptEx |
— |
+8,700 |
47.5K |
+22% |
— |
| D |
2026-05-21 16:04 |
2026-05-20 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
F - Tax |
$1.23 |
-4,688 |
42.9K |
-10% |
-$5,766 |
| D |
2026-05-18 16:07 |
2026-05-15 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
M - OptEx |
— |
+4,771 |
41.4K |
+13% |
— |
| D |
2026-05-18 16:07 |
2026-05-15 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
F - Tax |
$1.30 |
-2,571 |
38.8K |
-6% |
-$3,342 |
| DM |
2026-02-27 |
2026-02-26 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
F - Tax |
$1.79 |
-9,259 |
36.6K |
-20% |
-$16.6K |
| DM |
2026-02-27 |
2026-02-26 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
M - OptEx |
— |
+15.6K |
35.3K |
+80% |
— |
| D |
2025-05-16 |
2025-05-15 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
M - OptEx |
— |
+4,771 |
32.8K |
+17% |
— |
| D |
2025-05-16 |
2025-05-15 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
F - Tax |
$1.95 |
-2,566 |
30.3K |
-8% |
-$5,004 |
| DM |
2025-02-28 |
2025-02-26 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
M - OptEx |
— |
+9,007 |
31.0K |
+41% |
— |
| DM |
2025-02-28 |
2025-02-26 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
F - Tax |
$1.98 |
-5,322 |
28.1K |
-16% |
-$10.5K |
| D |
2024-05-16 |
2024-05-15 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
M - OptEx |
— |
+4,771 |
26.9K |
+22% |
— |
| D |
2024-05-16 |
2024-05-15 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
F - Tax |
$13.07 |
-2,562 |
24.4K |
-10% |
-$33.5K |
| DM |
2024-02-28 |
2024-02-26 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
M - OptEx |
— |
+5,875 |
24.5K |
+32% |
— |
| DM |
2024-02-28 |
2024-02-26 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
F - Tax |
$8.16 |
-3,466 |
20.5K |
-14% |
-$28.3K |
| D |
2023-03-13 |
2023-03-11 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
M - OptEx |
— |
+59.7K |
268.4K |
+29% |
— |
| D |
2023-03-13 |
2023-03-11 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
F - Tax |
$1.13 |
-31.4K |
237.0K |
-12% |
-$35.5K |
| DM |
2023-02-28 |
2023-02-26 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
M - OptEx |
— |
+70.5K |
236.9K |
+42% |
— |
| DM |
2023-02-28 |
2023-02-26 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
F - Tax |
$1.28 |
-41.1K |
208.7K |
-16% |
-$52.6K |
| D |
2022-03-14 |
2022-03-11 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
F - Tax |
$3.22 |
-31.4K |
179.3K |
-15% |
-$101.1K |
| D |
2022-03-14 |
2022-03-11 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
M - OptEx |
— |
+59.7K |
210.7K |
+40% |
— |
| D |
2022-03-09 |
2022-03-08 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
M - OptEx |
— |
+21.5K |
162.2K |
+15% |
— |
| D |
2022-03-09 |
2022-03-08 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
F - Tax |
$3.26 |
-11.3K |
151.0K |
-7% |
-$36.8K |
| D |
2022-03-01 |
2022-02-26 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
M - OptEx |
— |
+22.5K |
153.3K |
+17% |
— |
| D |
2022-03-01 |
2022-02-26 |
INO |
INOVIO PHARMACEUTICALS, INC. |
KIES PETER |
CFO |
F - Tax |
$3.22 |
-12.6K |
140.8K |
-8% |
-$40.4K |